Skip to content

Clinical trials

Phase 4 Hyperlipoproteinemia Type II trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipoproteinemia Type II Phase: Phase 4 Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20073
20141
20182
20191
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Daiichi Sankyo2
AstraZeneca1
B. Braun Medical Inc.1
Bahria University1
Columbia University1
Fundación Hipercolesterolemia Familiar1
Genzyme, a Sanofi Company1
In His Image1
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado1
National Heart Institute, Mexico1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipoproteinemia Type II12
Hypercholesterolemia4
Hyperlipidemias4
Dyslipidemias2
Coronary Disease1
Diabetes Mellitus, Type 21
Hyperlipidemia, Familial Combined1
Hyperlipoproteinemia Type IV1
Hyperlipoproteinemia Type V1
Hyperlipoproteinemias1

Trials

Showing 51 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.